Photons Induce Vesicular Exocytotic Release of Glutamate in a Power-Dependent Way

Increasing evidence indicates that photobiomodulation, based on tissue irradiation with photons in the red to near-infrared spectrum, may be an effective therapeutic approach to central nervous system disorders. Although nervous system functionality has been shown to be affected by photons in animal models, as well as in preliminary evidence in healthy subjects or in patients with neuropsychiatric disorders, the mechanisms involved in the photobiomodulation effects have not yet been clarified. We previously observed that photobiomodulation could stimulate glutamate release. Here, we investigate mechanisms potentially involved in the glutamate-releasing effect of photons from adult mouse cerebrocortical nerve terminals. We report evidence of photon ability to induce an exocytotic vesicular release of glutamate from the terminals of glutamatergic neurons in a power-dependent way. It can be hypothesized that photobiomodulation, depending on the potency, can release glutamate in a potentially neurotoxic or physiological range.

[1]  I. Gibson,et al.  Laser subtractive and laser powder bed fusion of metals: review of process and production features , 2023, Rapid Prototyping Journal.

[2]  Sufang Tang,et al.  Rapid-acting antidepressants targeting modulation of the glutamatergic system: clinical and preclinical evidence and mechanisms , 2022, General Psychiatry.

[3]  Michael R Hamblin,et al.  Photobiomodulation therapy in management of cancer therapy-induced side effects: WALT position paper 2022 , 2022, Frontiers in Oncology.

[4]  Jason H. Huang,et al.  Transcranial near-infrared light in treatment of neurodegenerative diseases , 2022, Frontiers in Pharmacology.

[5]  A. Benabid,et al.  The effect of photobiomodulation on the brain during wakefulness and sleep , 2022, Frontiers in Neuroscience.

[6]  E. Hascup,et al.  Friend or Foe? Defining the Role of Glutamate in Aging and Alzheimer’s Disease , 2022, Frontiers in Aging.

[7]  R. McIntyre Rapid-acting antidepressants in psychiatry: psychedelics, episodic treatments, innovation, and clarion call for methodologic rigor in drug development , 2022, Expert opinion on drug safety.

[8]  Douglas W. Barrett,et al.  Photobiomodulation of Cytochrome c Oxidase by Chronic Transcranial Laser in Young and Aged Brains , 2022, Frontiers in Neuroscience.

[9]  C. Simon,et al.  Photons guided by axons may enable backpropagation-based learning in the brain , 2022, bioRxiv.

[10]  J. Rizo Molecular Mechanisms Underlying Neurotransmitter Release. , 2022, Annual review of biophysics.

[11]  Quanguang Zhang,et al.  Non-invasive photobiomodulation treatment in an Alzheimer Disease-like transgenic rat model , 2022, Theranostics.

[12]  S. Benedicenti,et al.  A Narrative Review on Oral and Periodontal Bacteria Microbiota Photobiomodulation, through Visible and Near-Infrared Light: From the Origins to Modern Therapies , 2022, International journal of molecular sciences.

[13]  J. Mitrofanis,et al.  A Perspective on the Potential of Opsins as an Integral Mechanism of Photobiomodulation: It's Not Just the Eyes. , 2021, Photobiomodulation, photomedicine, and laser surgery.

[14]  P. Arany Photobiomodulation-Activated Latent Transforming Growth Factor-β1: A Critical Clinical Therapeutic Pathway and an Endogenous Optogenetic Tool for Discovery. , 2021, Photobiomodulation, photomedicine, and laser surgery.

[15]  Wensi Wu,et al.  Transcranial Photobiomodulation Therapy Ameliorates Perioperative Neurocognitive Disorder Through Modulation of Mitochondrial Function in Aged Mice , 2021, Neuroscience.

[16]  W. Bunney,et al.  Rapid-acting antidepressants and the circadian clock , 2021, Neuropsychopharmacology.

[17]  Dong-Sun Han,et al.  Photobiomodulation Promotes Hippocampal CA1 NSC Differentiation Toward Neurons and Facilitates Cognitive Function Recovery Involving NLRP3 Inflammasome Mitigation Following Global Cerebral Ischemia , 2021, Frontiers in Cellular Neuroscience.

[18]  D. Nosi,et al.  NIR Laser Photobiomodulation Induces Neuroprotection in an In Vitro Model of Cerebral Hypoxia/Ischemia , 2021, Molecular Neurobiology.

[19]  S. Benedicenti,et al.  Improving Consistency of Photobiomodulation Therapy: A Novel Flat-Top Beam Hand-Piece versus Standard Gaussian Probes on Mitochondrial Activity , 2021, International journal of molecular sciences.

[20]  C. Zarate,et al.  Novel Glutamatergic Modulators for the Treatment of Mood Disorders: Current Status , 2021, CNS Drugs.

[21]  S. Benedicenti,et al.  Mitochondrial Bioenergetic, Photobiomodulation and Trigeminal Branches Nerve Damage, What’s the Connection? A Review , 2021, International journal of molecular sciences.

[22]  S. Benedicenti,et al.  Experimental and Clinical Applications of Red and Near-Infrared Photobiomodulation on Endothelial Dysfunction: A Review , 2021, Biomedicines.

[23]  K. K. Mahato,et al.  The Molecular Mechanisms of Action of Photobiomodulation Against Neurodegenerative Diseases: A Systematic Review , 2020, Cellular and Molecular Neurobiology.

[24]  Tymish Y. Ohulchanskyy,et al.  Red and near-infrared light evokes Ca2+ influx, endoplasmic reticulum release and membrane depolarization in neurons and cancer cells. , 2020, Journal of photochemistry and photobiology. B, Biology.

[25]  T. Cassano,et al.  The Dual Role of Glutamatergic Neurotransmission in Alzheimer’s Disease: From Pathophysiology to Pharmacotherapy , 2020, International journal of molecular sciences.

[26]  Janet Iwasa,et al.  SynapsEM: Computer-Assisted Synapse Morphometry , 2020, bioRxiv.

[27]  F. Benfenati,et al.  Presynaptic L-Type Ca2+ Channels Increase Glutamate Release Probability and Excitatory Strength in the Hippocampus during Chronic Neuroinflammation , 2020, The Journal of Neuroscience.

[28]  Quanguang Zhang,et al.  Mitochondria as a target for neuroprotection: role of methylene blue and photobiomodulation , 2020, Translational Neurodegeneration.

[29]  R. Edwards,et al.  The mechanism and regulation of vesicular glutamate transport: Coordination with the synaptic vesicle cycle. , 2020, Biochimica et biophysica acta. Biomembranes.

[30]  Lesley A. McCollum,et al.  Ultrastructural evidence for glutamatergic dysregulation in schizophrenia , 2020, Schizophrenia Research.

[31]  Michael R Hamblin,et al.  Therapeutic potential of intranasal photobiomodulation therapy for neurological and neuropsychiatric disorders: a narrative review , 2019, Reviews in the neurosciences.

[32]  Michael R Hamblin,et al.  Transcranial Photobiomodulation Improves Cognitive Performance in Young Healthy Adults: A Systematic Review and Meta-Analysis. , 2019, Photobiomodulation, photomedicine, and laser surgery.

[33]  S. Benedicenti,et al.  The 808 nm and 980 nm infrared laser irradiation affects spore germination and stored calcium homeostasis: A comparative study using delivery hand-pieces with standard (Gaussian) or flat-top profile. , 2019, Journal of photochemistry and photobiology. B, Biology.

[34]  P. McGuire,et al.  Clinical Course, Neurobiology and Therapeutic Approaches to Treatment Resistant Schizophrenia. Toward an Integrated View , 2019, Front. Psychiatry.

[35]  Tymish Y. Ohulchanskyy,et al.  Red and near‐infrared light induces intracellular Ca2+ flux via the activation of glutamate N‐methyl‐D‐aspartate receptors , 2019, Journal of cellular physiology.

[36]  Michael R Hamblin,et al.  Photobiomodulation for Alzheimer's Disease: Has the Light Dawned? , 2019, Photonics.

[37]  R. Duman,et al.  Neurobiology of rapid acting antidepressants: convergent effects on GluA1-synaptic function , 2019, Molecular Psychiatry.

[38]  Hui Li,et al.  The Role of NMDA Receptors in Alzheimer’s Disease , 2019, Front. Neurosci..

[39]  S. Benedicenti,et al.  Photobiomodulation Affects Key Cellular Pathways of all Life‐Forms: Considerations on Old and New Laser Light Targets and the Calcium Issue , 2018, Photochemistry and photobiology.

[40]  L. Agnati,et al.  Near‐infrared laser photons induce glutamate release from cerebrocortical nerve terminals , 2018, Journal of biophotonics.

[41]  Michael R Hamblin,et al.  Photobiomodulation and Cancer: What Is the Truth? , 2018, Photomedicine and laser surgery.

[42]  Michael R Hamblin,et al.  Mechanisms and Mitochondrial Redox Signaling in Photobiomodulation , 2018, Photochemistry and photobiology.

[43]  Michael R Hamblin,et al.  Brain Photobiomodulation Therapy: a Narrative Review , 2018, Molecular Neurobiology.

[44]  K. Fuxe,et al.  A2A‐D2 receptor–receptor interaction modulates gliotransmitter release from striatal astrocyte processes , 2017, Journal of neurochemistry.

[45]  Stefano Benedicenti,et al.  Photobiomodulation by Infrared Diode Laser: Effects on Intracellular Calcium Concentration and Nitric Oxide Production of Paramecium , 2016, Photochemistry and photobiology.

[46]  Michael R. Hamblin,et al.  Shining light on the head: Photobiomodulation for brain disorders , 2016, BBA clinical.

[47]  J. Tuszynski,et al.  Possible existence of optical communication channels in the brain , 2016, Scientific Reports.

[48]  Michael R Hamblin,et al.  Review of transcranial photobiomodulation for major depressive disorder: targeting brain metabolism, inflammation, oxidative stress, and neurogenesis , 2016, Neurophotonics.

[49]  Michael R. Hamblin,et al.  Proposed Mechanisms of Photobiomodulation or Low-Level Light Therapy , 2016, IEEE Journal of Selected Topics in Quantum Electronics.

[50]  S. Benedicenti,et al.  808-nm laser therapy with a flat-top handpiece photobiomodulates mitochondria activities of Paramecium primaurelia (Protozoa) , 2016, Lasers in Medical Science.

[51]  N. Mercuri,et al.  Astrocyte-Dependent Vulnerability to Excitotoxicity in Spermine Oxidase-Overexpressing Mouse , 2016, NeuroMolecular Medicine.

[52]  L. Agnati,et al.  Calcium-permeable AMPA receptors trigger vesicular glutamate release from Bergmann gliosomes , 2015, Neuropharmacology.

[53]  S. Benedicenti,et al.  Effect of 808 nm Diode Laser on Swimming Behavior, Food Vacuole Formation and Endogenous ATP Production of Paramecium primaurelia (Protozoa) , 2015, Photochemistry and photobiology.

[54]  Jiapei Dai,et al.  Biophoton signal transmission and processing in the brain. , 2014, Journal of photochemistry and photobiology. B, Biology.

[55]  Michael R. Hamblin,et al.  Low‐level laser therapy (810 nm) protects primary cortical neurons against excitotoxicity in vitro , 2014, Journal of biophotonics.

[56]  N. Danbolt,et al.  Glutamate as a neurotransmitter in the healthy brain , 2014, Journal of Neural Transmission.

[57]  Jiapei Dai,et al.  Spatiotemporal Imaging of Glutamate-Induced Biophotonic Activities and Transmission in Neural Circuits , 2014, PloS one.

[58]  M. Marcoli,et al.  Flow Synthesis and Biological Studies of an Analgesic Adamantane Derivative That Inhibits P2X7-Evoked Glutamate Release. , 2013, ACS medicinal chemistry letters.

[59]  B. Bianco,et al.  Effects of an extremely low-frequency electromagnetic field on stress factors: a study in Dictyostelium discoideum cells. , 2013, European journal of protistology.

[60]  A. Harvey,et al.  Red/near-infrared irradiation therapy for treatment of central nervous system injuries and disorders , 2013, Reviews in the neurosciences.

[61]  A. Romano,et al.  Glutamatergic alterations and mitochondrial impairment in a murine model of Alzheimer disease , 2012, Neurobiology of Aging.

[62]  Botros B. Kostandy The role of glutamate in neuronal ischemic injury: the role of spark in fire , 2012, Neurological Sciences.

[63]  G. Sanacora,et al.  Towards a glutamate hypothesis of depression An emerging frontier of neuropsychopharmacology for mood disorders , 2012, Neuropharmacology.

[64]  William A Catterall,et al.  Voltage-Gated Calcium Channels , 2011 .

[65]  R. Bartha,et al.  Reduced hippocampal glutamate in Alzheimer disease , 2011, Neurobiology of Aging.

[66]  Thomas C. Südhof,et al.  RIM Proteins Tether Ca2+ Channels to Presynaptic Active Zones via a Direct PDZ-Domain Interaction , 2011, Cell.

[67]  Ben A. Barres,et al.  Regulation of synaptic connectivity by glia , 2010, Nature.

[68]  M. Marcoli,et al.  Urotensin II receptor and acetylcholine release from mouse cervical spinal cord nerve terminals , 2010, Neuroscience.

[69]  M. Marcoli,et al.  Inhibition of Presynaptic Release-Facilitatory Kainate Autoreceptors by Extracellular Cyclic GMP , 2010, Journal of Pharmacology and Experimental Therapeutics.

[70]  David G. Nicholls,et al.  Bioenergetic analysis of isolated cerebrocortical nerve terminals on a microgram scale: spare respiratory capacity and stochastic mitochondrial failure , 2009, Journal of neurochemistry.

[71]  Z. Qin,et al.  Molecular mechanisms of excitotoxicity and their relevance to pathogenesis of neurodegenerative diseases , 2009, Acta Pharmacologica Sinica.

[72]  M. Mattson,et al.  Glutamate and Neurotrophic Factors in Neuronal Plasticity and Disease , 2008, Annals of the New York Academy of Sciences.

[73]  R. Shigemoto,et al.  Glutamate and GABA receptor signalling in the developing brain , 2005, Neuroscience.

[74]  D. Javitt Glutamate receptors as therapeutic targets , 2004, Molecular Psychiatry.

[75]  H. Bellen,et al.  The architecture of the active zone in the presynaptic nerve terminal. , 2004, Physiology.

[76]  T. Südhof,et al.  α-Neurexins couple Ca2+ channels to synaptic vesicle exocytosis , 2003, Nature.

[77]  J. Sánchez-Prieto,et al.  Differential coupling of N- and P/Q-type calcium channels to glutamate exocytosis in the rat cerebral cortex , 2002, Neuroscience Letters.

[78]  G. Zamponi,et al.  Interactions between presynaptic Ca2+ channels, cytoplasmic messengers and proteins of the synaptic vesicle release complex. , 2001, Trends in pharmacological sciences.

[79]  T. Ueda,et al.  Inhibition of vesicular glutamate storage and exocytotic release by Rose Bengal , 2001, Journal of neurochemistry.

[80]  T. Chase,et al.  Striatal dopamine- and glutamate-mediated dysregulation in experimental parkinsonism , 2000, Trends in Neurosciences.

[81]  F. Mora,et al.  Effects of 4-Aminopyridine on Extracellular Concentrations of Glutamate in Striatum of the Freely Moving Rat , 1997, Neurochemical Research.

[82]  J. Urenjak,et al.  Is high extracellular glutamate the key to excitotoxicity in traumatic brain injury? , 1997, Journal of neurotrauma.

[83]  J. Sánchez-Prieto,et al.  Presynaptic Modulation of Glutamate Release Targets Different Calcium Channels in Rat Cerebrocortical Nerve Terminals , 1997, The European journal of neuroscience.

[84]  Paul Greengard,et al.  Distinct pools of synaptic vesicles in neurotransmitter release , 1995, Nature.

[85]  R. Tapia,et al.  Effect of 4-aminopyridine on transmitter release in synaptosomes , 1982, Brain Research.

[86]  Michael R Hamblin Mechanisms of photobiomodulation in the brain , 2019, Photobiomodulation in the Brain.

[87]  Qianqian Fang,et al.  Selective photobiomodulation for emotion regulation: model-based dosimetry study , 2019, Neurophotonics.

[88]  P. Reddy,et al.  Role of Glutamate and NMDA Receptors in Alzheimer's Disease. , 2017, Journal of Alzheimer's disease : JAD.

[89]  Y. Moriyama,et al.  Vesicular neurotransmitter transporters: an approach for studying transporters with purified proteins. , 2013, Physiology.

[90]  Luis De Taboada,et al.  Transcranial laser therapy attenuates amyloid-β peptide neuropathology in amyloid-β protein precursor transgenic mice. , 2011, Journal of Alzheimer's disease : JAD.

[91]  F. Chaudhry,et al.  Pharmacology of neurotransmitter transport into secretory vesicles. , 2008, Handbook of experimental pharmacology.

[92]  W. Mcentee,et al.  Glutamate: its role in learning, memory, and the aging brain , 2005, Psychopharmacology.

[93]  T. Sudhof,et al.  The synaptic vesicle cycle. , 2004, Annual review of neuroscience.

[94]  C. Garner,et al.  The presynaptic cytomatrix of brain synapses , 2001, Cellular and Molecular Life Sciences CMLS.

[95]  T. Südhof,et al.  The Synaptic Vesicle Cycle in the Nerve Terminal , 1999 .

[96]  D. Nicholls Chapter 2 Presynaptic modulation of glutamate release , 1998 .